Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07361549) titled 'Localized Injection of Lidocaine Via the Middle Meningeal Artery for Intractable Headache Treatment' on Jan. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Daniel A Tonetti, MD
Condition:
Refractory Migraine
Headache
Intervention:
Drug: Lidocaine (drug)
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: March 2026
Target Sample Size: 80
Countries of Recruitment:
United States
To know more, visit https://clini...